4//SEC Filing
DesRosier Thomas 4
Accession 0000950170-25-023573
CIK 0001609809other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 8:07 PM ET
Size
12.9 KB
Accession
0000950170-25-023573
Insider Transaction Report
Form 4
DesRosier Thomas
Chief Legal Officer and EVP
Transactions
- Exercise/Conversion
Restricted Stock Units
2025-02-15−2,657→ 21,250 total→ Common Stock (2,657 underlying) - Exercise/Conversion
Common Stock
2025-02-15+2,657→ 137,849 total - Exercise/Conversion
Common Stock
2025-02-15+8,907→ 146,756 total - Sale
Common Stock
2025-02-18$0.81/sh−4,300$3,485→ 142,456 total - Exercise/Conversion
Restricted Stock Units
2025-02-15−8,907→ 26,718 total→ Common Stock (8,907 underlying)
Footnotes (5)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 instruction adopted by the reporting person on March 2, 2023, solely with the intent to cover taxes in connection with the vesting of the restricted stock units.
- [F3]The price reported in column 4 is a weighted average of the sale prices. These shares were sold in multiple transactions at prices ranging from $0.81 to $0.8385, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The restricted stock units have vested and settled as to 25% of the restricted stock units on February 15, 2024. The remainder of the restricted stock units have vested and settled or will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date.
- [F5]The restricted stock units have vested and settled as to 25% of the restricted stock units on February 15, 2025. The remainder of the restricted stock units have vested and settled or will vest and settle in 12 equal quarterly installments thereafter. The restricted stock units have no expiration date.
Documents
Issuer
Seres Therapeutics, Inc.
CIK 0001609809
Entity typeother
Related Parties
1- filerCIK 0001435744
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 8:07 PM ET
- Size
- 12.9 KB